Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 8.88 is 18% above its 3-year average of 7.51, around the middle of its 3-year range (0.00–15.88).
As of the fiscal period ended Tuesday, June 30, 2026. 17.09% below its 12-month average of 10.71.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 8.88.
CURRENT RATIO
8.88
CURRENT RATIO AVG TTM
10.71
CURRENT RATIO AVG 3Y
7.51
CURRENT RATIO AVG 5Y
N/A
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-17.09%
CURRENT VS 3Y AVG
+18.26%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.57
median of 739 covered companies
CURRENT VS SECTOR MEDIAN
+148.74%
vs the sector median at left
Market Cap
$840.45M
Current Ratio
1.39
TTM Avg
1.36
3Y Avg
1.46
5Y Avg
2.28
Market Cap
$859.14M
Current Ratio
9.52
TTM Avg
4.26
3Y Avg
6.09
5Y Avg
7.80
Market Cap
$824.96M
Current Ratio
14.93
TTM Avg
20.63
3Y Avg
16.30
5Y Avg
22.70
Market Cap
$819.99M
Current Ratio
4.92
TTM Avg
7.19
3Y Avg
6.36
5Y Avg
8.34
Market Cap
$874.76M
Current Ratio
1.95
TTM Avg
2.27
3Y Avg
2.05
5Y Avg
2.13
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | $844.23M | 8.88 | 10.71 | 7.51 | N/A |
| Alumis Inc. (ALMS)vs › | $847.45M | 6.74 | 5.17 | 5.15 | 5.15 |
| QuidelOrtho Corporation (QDEL)vs › | $840.45M | 1.39 | 1.36 | 1.46 | 2.28 |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $859.14M | 9.52 | 4.26 | 6.09 | 7.80 |
| Jade Biosciences, Inc. (JBIO)vs › | $824.96M | 14.93 | 20.63 | 16.30 | 22.70 |
| Pacific Biosciences of California, Inc. (PACB)vs › | $819.99M | 4.92 | 7.19 | 6.36 | 8.34 |
| Rigel Pharmaceuticals, Inc. (RIGL)vs › | $874.76M | 1.95 | 2.27 | 2.05 | 2.13 |
| Ardelyx, Inc. (ARDX)vs › | $812.21M | 3.34 | 4.45 | 4.03 | 4.25 |
| InMode Ltd. (INMD)vs › | $805.46M | 8.18 | 10.05 | 10.24 | 9.72 |
| Corvus Pharmaceuticals, Inc. (CRVS)vs › | $883.79M | 16.16 | 3.88 | 3.97 | 4.50 |
Current Ratio
8.88
Quick Ratio
7.96
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 8.88 |
| 2026-03-31 | 10.69 |
| 2025-12-31 | 8.66 |
| 2025-09-30 | 10.64 |
| 2025-06-30 | 14.68 |
| 2025-03-31 | 15.88 |
| 2024-12-31 | 6.29 |
| 2024-09-30 | 4.62 |
| 2024-06-30 | 0.00 |
| 2024-03-31 | 0.00 |
| 2023-12-31 | 9.77 |
| 2023-09-30 | 0.00 |
